NM_005228.5:c.2237_2248delAATTAAGAGAAGinsCAC

Variant names:

• chr7-55174774-AATTAAGAGAAG-CAC
• rs727503015
• NM_005228.5:c.2237_2248delAATTAAGAGAAGinsCAC

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1 PM2 PM4 PP3

The NM_005228.5(EGFR):​c.2237_2248delAATTAAGAGAAGinsCAC​(p.Glu746_Ala750delinsAlaPro) variant causes a missense, disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as drug response (no stars). Synonymous variant affecting the same amino acid position has been classified as Likely pathogenic.

• Frequency: Genomes: not found (cov: 33)
• Consequence: EGFR NM_005228.5 missense, disruptive_inframe_deletion
• Clinical Significance: drug response no assertion criteria provided O:1
• Conservation: PhyloP100: 9.89
• Publications: 2 publications found

Genes affected

EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]

EGFR Gene-Disease associations (from GenCC):

• lung cancer

  Inheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
• non-small cell lung carcinoma

  Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
• inflammatory skin and bowel disease, neonatal, 2

  Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
• neonatal inflammatory skin and bowel disease

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

ACMG classification

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

• PM1: In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 29 uncertain in NM_005228.5
• PM2: Very rare variant in population databases, with high coverage
• PM4: Nonframeshift variant in NON repetitive region in NM_005228.5.
• PP3: No computational evidence supports a deleterious effect, but strongly conserved according to phyloP

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005228.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	EGFR	NM_005228.5	MANE Select	c.2237_2248delAATTAAGAGAAGinsCAC	p.Glu746_Ala750delinsAlaPro	missense disruptive_inframe_deletion	N/A	NP_005219.2
	EGFR	NM_001346899.2		c.2102_2113delAATTAAGAGAAGinsCAC	p.Glu701_Ala705delinsAlaPro	missense disruptive_inframe_deletion	N/A	NP_001333828.1
	EGFR	NM_001346900.2		c.2078_2089delAATTAAGAGAAGinsCAC	p.Glu693_Ala697delinsAlaPro	missense disruptive_inframe_deletion	N/A	NP_001333829.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	EGFR	ENST00000275493.7	TSL:1 MANE Select	c.2237_2248delAATTAAGAGAAGinsCAC	p.Glu746_Ala750delinsAlaPro	missense disruptive_inframe_deletion	N/A	ENSP00000275493.2
	EGFR	ENST00000455089.5	TSL:1	c.2102_2113delAATTAAGAGAAGinsCAC	p.Glu701_Ala705delinsAlaPro	missense disruptive_inframe_deletion	N/A	ENSP00000415559.1
	EGFR	ENST00000450046.2	TSL:4	c.2078_2089delAATTAAGAGAAGinsCAC	p.Glu693_Ala697delinsAlaPro	missense disruptive_inframe_deletion	N/A	ENSP00000413354.2

Frequencies

GnomAD3 genomes Cov.: 33

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome Cov.: 33

ClinVar

Significance: drug response

Submissions summary: Other:1

Revision: no assertion criteria provided

Submissions by phenotype

Tyrosine kinase inhibitor response Other:1

Mar 01, 2008

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance: drug response

Review Status: no assertion criteria provided

Collection Method: clinical testing

Likely Responsive

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
PhyloP100		9.9

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs727503015; hg19: chr7-55242467; COSMIC: COSV51777590;